Results for tag: "Topical Corticosteroids"

Topical corticosteroids form an essential class of anti-inflammatory and immunosuppressive drugs widely used in healthcare services for the treatment of a variety of dermatological conditions. They are administered directly onto the skin to relieve inflammation, itching, and irritation caused by conditions such as eczema, psoriasis, allergic reactions, and rashes. These medications vary in potency, ranging from mild to ultra-high, thus allowing practitioners to tailor treatment plans based on the severity of the patient's condition. Within healthcare services, topical corticosteroids are also leveraged in conjunction with other treatments to manage chronic skin diseases effectively. The market for these drugs is characterized by an extensive range of products, including creams, ointments, lotions, gels, and foams, which are often available by prescription but can also include over-the-counter options for milder applications. Several pharmaceutical companies partake in the production and distribution of topical corticosteroids. Key players typically include large, multinational corporations as well as specialized dermatology companies. Some noteworthy participants in this market include Pfizer Inc., Novartis AG, Merck & Co., Inc., GlaxoSmithKline plc, Sanofi, and Johnson & Johnson. Additionally, a number of generic drug manufacturers contribute to the market, offering more cost-effective therapeutic alternatives. Show Less Read more